@article{ref1,
title="Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective",
journal="Psychiatry research",
year="2017",
author="Veras, Andre B. and Cougo, Simone and Meira, Fernanda and Peixoto, Clayton and Barros, Jorge A. and Nardi, Antonio E. and Malaspina, Dolores and Poyurovsky, Michael and Kahn, Jeffrey P.",
volume="257",
number="",
pages="172-178",
abstract="Twenty patients with DSM5 schizophrenia were comprehensively and formally assessed by an experienced psychiatrist. All subjects were assessed for: positive and negative psychotic symptoms; social anxiety; panic anxiety; obsessive compulsive disorder, atypical depression; major depression; suicide risk; and global assessment of functioning. Different profiles of clinical presentation and symptom evolution emerged for patients with schizophrenia who had co-morbid depression (15%), OCD (15%), panic or limited symptom attacks (55%) and social anxiety (5%). At least eighty percent of the sample had one or more of these co-morbidities. Summing up, the data support our previous finding that panic is highly prevalent in Schizophrenia with Auditory Hallucinations (>73% here, versus 100% before), and panic was paroxysmally concurrent with voice onset. Moreover, characteristic clinical findings may help point clinicians to five specific co-morbidity psychosis subtypes. Moreover, co-morbidity dissection of psychotic diagnoses recalls and parallels the historical psychopharmacologic dissection of non-psychotic anxiety and depressive subtypes diagnoses. Larger studies should further test and explore these preliminary findings.<p /><p>Language: en</p>",
language="en",
issn="0165-1781",
doi="10.1016/j.psychres.2017.07.048",
url="http://dx.doi.org/10.1016/j.psychres.2017.07.048"
}